The forecasted import of Phenazone (Antipyrin) to Canada shows a consistent upward trend from 2024 through 2028. Starting at 505.34 thousand kilograms in 2024, it increases steadily to reach 597.0 thousand kilograms by 2028. Compared to 2023, this projection indicates a significant growth trajectory. The year-on-year variation demonstrates a consistent rise, with an upward growth rate averaging around 4-5% annually. The Compound Annual Growth Rate (CAGR) over this five-year period reflects a positive trend, indicative of strong demand or increasing need for imports of this pharmaceutical compound.

Key future trends to watch for include:

Potential shifts in Canadian healthcare regulations impacting import levels.
Evolving technology and synthesis methods possibly altering global Phenazone production and pricing.
Changes in domestic production capacity and capabilities in Canada.